Telangiectasias induced by combination tucatinib and ado-trastuzumab emtansine in a patient with metastatic breast cancer
CONCLUSIONS: We postulate that telangiectasias may be a previously unreported dermatologic side effect of combination treatment with tucatinib and T-DM1. Electrocautery is a safe and effective procedure to reduce the appearance of telangiectasias and improve patient satisfaction during chemotherapy.PMID:38578876 | DOI:10.3233/BD-230053
Source: Breast Disease - Category: Cancer & Oncology Authors: Gabriella F Rodriguez Anuj Shah Andrea D Maderal Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Colorectal Cancer | Dermatology | Ductal Carcinoma | HER2 | Herceptin | Skin